✦ LIBER ✦

Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells

✍ Scribed by AngelaJ. Mantha; KathrynE. McFee; Nima Niknejad; Glenwood Goss; IanA. Lorimer; Jim Dimitroulakos

Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 611 KB
Volume: 129
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-003-0490-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor targete

Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck

✍ Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR

Characterization, quantification, and po

Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas

✍ Dr. José Santini; Dr. Jean-Louis Formento; Dr. Mireille Francoual; Dr. Gérard Mi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 661 KB

Epidermal growth factor (EGF) stimulates the growth of several types of epithelial tissues and possesses a strong mitogenic activity that is mediated through its cell surface receptor (EGFR). The aim of this study was to characterize EGFR and measure its levels in head and neck tumors biopsies (70 p

Autocrine epidermal growth factor recept

Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines

✍ Goro Oshima; Johan Wennerberg; Takashi Yamatodani; Elisabeth Kjellén; Hiroyuki M 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 328 KB

Targeted therapies in squamous cell carc

Targeted therapies in squamous cell carcinoma of the head and neck

✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r

Gene amplification and overexpression of

Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck

✍ Drs. Koichi Rikimaru; Drs. Keiko Tadokoro; Dr. Tadashi Yamamoto; Drs. Shoji Enom 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

## Abstract The degree of gene amplification for epidermal growth factor receptor (EGFR) and its expression levels were examined in 4 cases of tumor lesions and their cell lines of human squamous cell carcinoma (SCC) of the oral cavity. The amplification was detected in 1 case (ZA), but not signifi

Radiolabeled cetuximab: Dose optimizatio

Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model

✍ Bianca A.W. Hoeben; Janneke D.M. Molkenboer-Kuenen; Wim J.G. Oyen; Wenny J.M. Pe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 563 KB

## Abstract Noninvasive imaging of the epidermal growth factor receptor (EGFR) in head‐and‐neck squamous cell carcinoma could be of value to select patients for EGFR‐targeted therapy. We assessed dose optimization of ^111^Indium‐DTPA‐cetuximab (^111^In‐cetuximab) for EGFR imaging in a head‐and‐neck